This week, the brain uses special wiring to assess facial hues, NEI director Paul Sieving retires to California and a British woman dies after impaling her eye on a metal straw. Source: AAO
Investigators of this multicenter cross-sectional, observational cohort study examined the clinical and epidemiologic characteristics of optic neuritis in Japan. Source: AAO
In this retrospective analysis, the authors compared outcomes in patients treated with prosthetic replacement of the ocular surface ecosystem (PROSE) versus other standard-of-care treatments for postsurgical lagophthalmos and exposure keratopathy. Source: AAO
This study investigated the expression levels of inflammatory cytokines in the conjunctival epithelium and correlations with clinical parameters in dry eye disease. Source: AAO
This study assessed the safety and efficacy of ab interno implantation of iStent inject in combination with cataract surgery in patients with primary open-angle glaucoma. Source: AAO
Altaire Pharmaceuticals has voluntarily recalled 150 lots of 23 ophthalmic products due to the potential for nonsterility. Source: AAO
This week, a bevacizumab biosimilar wins FDA approval, doctors remove an entrapped eyelash from a conjunctival ulcer and Oxurion’s plasma kallikrein inhibitor resolves diabetic macular edema in a phase 1 study. Source: AAO
Investigators prospectively examined the association between the progression of retinopathy and kidney disease. Source: AAO
This study evaluated the overall prevalence, annual prevalence and incidence of dry eye disease in a large, representative population in the United States. Source: AAO
Eculizumab (Soliris), a first-in-class complement inhibitor, is now approved for AQP4 antibody-positive neuromyelitis optica spectrum disorder (NMOSD) following an expedited 6-month priority review. Source: AAO